share_log

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25

摩根士丹利將Vaccitech的評級下調至同等權重,將目標股價下調至3.25美元
Benzinga ·  2023/09/25 05:41

Morgan Stanley analyst Matthew Harrison downgrades Vaccitech (NASDAQ:VACC) from Overweight to Equal-Weight and lowers the price target from $14 to $3.25.

摩根士丹利分析師馬修·哈裡森將納斯達克(股票代碼:VACC)的評級從增持下調至持平,並將目標價從14美元下調至3.25美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論